Request Free Sample ×
Prefilled Syringes Market Research Report - Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Prefilled Syringes Market

ID: MRFR/MED/4708-CR
157 Pages
Rahul Gotadki
Last Updated: May 06, 2026

Prefilled Syringes Market Research Report: Size, Share, Trend Analysis By Applications (Vaccination, Autoimmune Diseases, Diabetes Management, Hormonal Therapy, Oncology), By Material Type (Plastic, Glass, Metal), By Filling Type (Liquid, Lyophilized, Powder), By End Use (Hospitals, Home Healthcare, Pharmaceutical Companies, Research Laboratories) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Prefilled Syringes Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Prefilled Syringes Market Summary

The Global Prefilled Syringes Market size was valued at USD 7.64 Billion in 2024, and the market is projected to grow from USD 8.36 Billion in 2025 to USD 20.63 Billion by 2035, registering a CAGR of 9.45% during the forecast period 2025–2035. North America led the market in 2024 with over 40.58% share, generating around USD 3.8 Billion in revenue.
 
Rising prevalence of chronic diseases and expanding global immunization programs are driving strong adoption of prefilled syringes. Increasing demand for safer, precise, and self-administered drug delivery systems further supports market expansion across vaccines and biologics globally.
 
According to the World Health Organization (WHO), immunization prevents 4–5 million deaths annually from diseases such as diphtheria, tetanus, pertussis, influenza, and measles, significantly increasing demand for advanced injectable delivery systems like prefilled syringes.
 
Additionally, the Centers for Disease Control and Prevention (CDC) reports that approximately 38.4 million people in the United States have diabetes, highlighting the rising need for self-administered injectable therapies. The Institute for Health Metrics and Evaluation (IHME) estimates over 529 million adults globally living with diabetes (2021), further strengthening long-term demand for accurate and safe drug delivery solutions.

Key Market Trends & Highlights

The Prefilled Syringes Market is experiencing robust growth driven by technological advancements and increasing demand for self-administration.

  • Vaccination application leads with 62% share, driven by global immunization programs and increasing preventive healthcare adoption worldwide.
  • Hospitals dominate end-use segment with 55% share due to high injectable medication usage and inpatient treatment demand.
  • Online retail holds 45% distribution share, driven by rising digital healthcare adoption and patient convenience purchasing trends.
  • North America leads with 40.58% revenue share; Europe follows with 30% share valued at USD 2.29B (2024).

Market Size & Forecast

2024 Market Size 7.64 (USD Billion)
2035 Market Size 20.63 (USD Billion)
CAGR (2025 - 2035) 9.45%

Major Players

Companies such as AbbVie (US), Becton Dickinson and Company (US), Gerresheimer AG (DE), Schott AG (DE), Fresenius Kabi AG (DE), Syringe Manufacturing Corporation (US), Medtronic(US), West Pharmaceutical Services (US), Nipro Corporation (JP) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Prefilled Syringes Market Trends

The Prefilled Syringes Market is currently experiencing a notable transformation, driven by advancements in technology and increasing demand for efficient drug delivery systems. The convenience offered by prefilled syringes, which eliminate the need for manual filling, is appealing to both healthcare providers and patients. This market is characterized by a growing preference for self-administration of medications, particularly in chronic disease management, where patients benefit from ease of use and reduced risk of dosing errors. 

Furthermore, the rise in biologics and biosimilars is propelling the development of specialized prefilled syringes designed to accommodate these complex formulations. In addition to technological innovations, regulatory support is fostering growth within the Prefilled Syringes Industry. Regulatory bodies are increasingly recognizing the advantages of prefilled syringes in enhancing patient safety and compliance. 

As a result, manufacturers are focusing on improving the design and functionality of these devices, ensuring they meet stringent safety standards. The global market landscape is also evolving with the entry of new players, which is likely to intensify competition and drive further advancements. Overall, the Prefilled Syringes Industry appears poised for continued expansion, reflecting broader trends in healthcare towards more efficient and patient-centric solutions.

Technological Advancements

The global industry is witnessing rapid technological innovations that enhance the functionality and safety of these devices. Manufacturers are investing in smart technologies, such as integrated sensors and digital tracking systems, which may improve patient adherence and provide real-time data to healthcare providers.

  • Technological advancements in drug delivery systems are improving safety and adherence through smart syringes, sensor integration, and digital tracking solutions. These innovations support better patient monitoring and reduced medication errors. According to WHO immunization reports, vaccines prevent 4–5 million deaths annually, reinforcing demand for highly precise delivery technologies. Gavi, the Vaccine Alliance has supported immunization of over 1 billion children in low-income countries since inception, driving innovation in injectable systems.

Rising Demand for Self-Administration

There is a growing trend towards self-administration of medications, particularly among patients with chronic conditions. Prefilled syringes facilitate this shift by offering a user-friendly solution that empowers patients to manage their treatments independently, potentially leading to improved health outcomes.

  • The increasing shift toward self-administration is supported by rising chronic disease prevalence and patient convenience needs. Prefilled syringes enable safe home-based treatment, reducing hospital dependency. CDC data shows 38.4 million Americans have diabetes, many requiring regular injectable insulin therapy. IHME highlights over 529 million global diabetes cases, reinforcing the demand for self-injectable drug delivery solutions that improve adherence and long-term disease management outcomes.

Regulatory Support and Compliance

Regulatory agencies are increasingly recognizing the advantages of prefilled syringes, leading to more favorable approval processes. This support is encouraging prefilled syringe manufacturers to invest in the development of new products that comply with safety standards. As regulations evolve, the global market is likely to benefit from enhanced credibility and wider acceptance in various therapeutic areas.

  • Regulatory agencies are strengthening approval frameworks for safer injectable systems, encouraging innovation in prefilled syringe design and compliance standards. The European Centre for Disease Prevention and Control (ECDC) reports sustained vaccination coverage efforts across Europe, maintaining measles immunization targets near 95% coverage levels in several regions, supporting adoption of advanced delivery devices. WHO emphasizes that immunization programs globally prevent millions of deaths annually, reinforcing regulatory support for safer injection technologies.

Prefilled Syringes Market Drivers

Market Growth Projections

The Global Prefilled Syringes Market Industry is poised for substantial growth, with projections indicating a market value of 5.06 USD Billion in 2024 and an anticipated increase to 9.5 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 5.89% from 2025 to 2035.
 
Factors contributing to this expansion include the rising demand for self-administration, technological advancements, and the increasing prevalence of chronic diseases. The global market's evolution reflects broader trends in healthcare, emphasizing the need for efficient and patient-friendly drug delivery systems.

Increase in Biologics and Biosimilars

The rise of biologics and biosimilars significantly influences the Global Prefilled Syringes Market Industry. As more biologic therapies are developed, the need for efficient delivery systems becomes paramount. Prefilled syringes offer a reliable method for administering these complex medications, ensuring accurate dosing and minimizing waste.
 
The increasing approval of biosimilars is expected to further drive demand, as these products often utilize prefilled syringes for patient administration. This trend suggests a strong growth potential, with the global market projected to expand at a CAGR of 5.89% from 2025 to 2035, reflecting the evolving landscape of the Global market.

Rising Demand for Self-Administration

The Global Prefilled Syringes Market Industry experiences a notable increase in demand for self-administration devices. Patients prefer prefilled syringes due to their convenience and ease of use, particularly for chronic conditions requiring regular medication. This trend is supported by the growing prevalence of diseases such as diabetes and rheumatoid arthritis, which necessitate frequent injections.
 
As a result, the global industry is projected to reach 5.06 USD Billion in 2024, indicating a robust growth trajectory. The self-administration trend not only enhances patient compliance but also reduces the burden on healthcare systems, thereby driving the expansion of the global market.

Regulatory Support and Standardization

Regulatory frameworks and standardization initiatives are pivotal in shaping the Global Prefilled Syringes Market Industry. Governments and health authorities are increasingly recognizing the importance of prefilled syringes in enhancing patient safety and treatment efficacy. Initiatives aimed at standardizing manufacturing processes and ensuring quality control are likely to bolster market confidence.
 
For instance, guidelines from health organizations promote the use of prefilled syringes in vaccination campaigns, further driving their adoption. This regulatory support is expected to facilitate market growth, contributing to the anticipated increase in market value to 9.5 USD Billion by 2035.

Growing Focus on Patient-Centric Healthcare

The Global Prefilled Syringes Market Industry is witnessing a shift towards patient-centric healthcare models. This approach emphasizes the importance of patient experience and outcomes, leading to an increased preference for user-friendly drug delivery systems. Prefilled syringes align with this trend by offering ease of use and reducing the need for professional administration.
 
As healthcare providers prioritize patient satisfaction, the demand for prefilled syringes is likely to rise. This shift may contribute to the overall growth of the global market, with projections indicating a market value of 5.06 USD Billion in 2024, reflecting the changing dynamics of healthcare delivery.

Technological Advancements in Syringe Design

Technological innovations play a crucial role in shaping the Global Prefilled Syringes Market Industry. Enhanced designs, such as safety features and improved materials, contribute to better user experiences and reduced risks of needle-stick injuries. For instance, advancements in polymer technology have led to the development of syringes that are lighter and more durable.
 
These innovations are likely to attract both manufacturers and healthcare providers, thereby expanding market opportunities. The ongoing investment in research and development suggests that the global market will continue to evolve, potentially reaching 9.5 USD Billion by 2035.

Market Segment Insights

By Application: Vaccination (Largest) vs. Autoimmune Diseases (Fastest-Growing)

The Prefilled Syringes Market is significantly influenced by various applications, with vaccination leading the global market, holding a 62% share. This segment benefits from the increasing global immunization efforts and public health initiatives aimed at improving vaccination rates. Autoimmune diseases are emerging as a pivotal segment as well, attributed to rising prevalence and heightened awareness for treatment options. Special attention is being drawn to the convenience and reduced risk of contamination provided by prefilled syringes, enhancing their adoption across sectors.

Vaccination (Dominant) vs. Autoimmune Diseases (Emerging)

The vaccination segment represents the dominant force in the global market due to its pivotal role in public health initiatives and global vaccination campaigns. With an emphasis on safety, prefilled syringes minimize the chance of cross-contamination, positioning them as a preferred option for immunizations. Conversely, the autoimmune diseases segment is emerging rapidly, driven by a surge in cases and ongoing advancements in treatment protocols. This growth is supported by the rising demand for patient-friendly delivery systems, making prefilled syringes an attractive choice for both healthcare providers and patients in managing chronic conditions.

By End Use: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the Prefilled Syringes Market, hospitals constitute the largest segment at 55%, driven by their extensive use in inpatient settings for medication delivery and vaccinations. Following hospitals, home care settings are gaining traction, largely due to the increasing preference for self-administration and the rise of chronic diseases that necessitate long-term medication management. Ambulatory surgical centers and pharmacies also contribute to the global market, albeit on a smaller scale, focusing on outpatient procedures and prescription medication distribution.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals dominate the global market due to their critical role in delivering injectable medications, particularly in emergency and surgical situations. The stringent regulatory standards and the need for quality assurance in hospitals further emphasize their reliance on prefilled syringes, which offer precision and safety. In contrast, home care settings are emerging as a significant segment, appealing to patients who prefer self-administration of medications in a more comfortable environment. This shift is driven by technological advancements that simplify syringe user interface and the growing awareness of chronic disease management and preventive care.

By Material: Glass (Largest) vs. Plastic (Fastest-Growing)

The Prefilled Syringes Market exhibits a diverse material landscape, where glass syringes maintain the largest market share at 60% due to their excellent barrier properties, which enhance drug stability and shelf life. In contrast, the demand for Plastic prefilled syringes is rapidly increasing as they offer advantageous features like flexibility, reduced weight, and manufacturing cost-effectiveness, appealing significantly to pharmaceutical companies and healthcare providers looking for innovative solutions. Growth trends in the material segment are propelled by technological advancements in plastic formulation and manufacturing techniques, making the production of Plastic syringes more efficient and cost-effective. Additionally, the rise in self-administration practices among patients and the growing prevalence of chronic diseases necessitate user-friendly delivery systems, further driving the adoption of both Glass and Plastic prefilled syringes in various therapeutic areas.

Glass (Dominant) vs. Plastic (Emerging)

In the global market, Glass syringes are recognized as the dominant segment due to their unparalleled stability and suitability for a wide range of viscoelastic drugs. They are particularly favored for biologics, where maintaining drug integrity is critical. Conversely, Plastic syringes are emerging as a viable alternative, appealing to manufacturers for their lightweight and shatterproof characteristics, making them safer for storage and handling. As manufacturers innovate with biocompatible plastics, this segment is expected to grow rapidly, driven by trends towards patient-centric design and the need for disposable syringes that minimize contamination risks.

By Filling Volume: Less than 1 ml (Largest) vs. 1 ml to 5 ml (Fastest-Growing)

In the Prefilled Syringes Market, the filling volume segment displays significant diversity, with the “Less than 1 ml” category holding the largest share at 55%. This segment is predominantly utilized in the administration of vaccines and biologics, which require low dosages. Meanwhile, the '1 ml to 5 ml' segment is showing rapid growth due to its increasing adoption in various therapeutic applications, including diabetes management and rheumatoid arthritis treatment. This growth is driven by the need for precise dosing and ease of administration, which these volumes effectively provide.

Less than 1 ml (Dominant) vs. 1 ml to 5 ml (Emerging)

The 'Less than 1 ml' filling volume in prefilled syringes is crucial in the global industry, established primarily for its use in vaccinations and emergency medicine. Its dominant position is solidified by the rising demand for vaccines, especially in the wake of global health challenges. On the other hand, the '1 ml to 5 ml' segment is emerging rapidly, catering to a broader range of therapeutic areas. This segment appeals to healthcare providers for its versatility, supporting both self-administration and clinical settings, thus reflecting the evolving needs of patients and practitioners alike.

By Design Type: Single-Chamber (Largest) vs. Dual-Chamber (Fastest-Growing)

In the Prefilled Syringes Market, the design type segment is primarily characterized by three key configurations: Single-Chamber, Dual-Chamber, and Pre-assembled. Among these, Single-Chamber prefilled syringes dominate the global industry due to their widespread use in various therapeutic applications. In contrast, the Dual-Chamber segment is emerging as the fastest-growing option, appealing to consumers who seek convenience and stability in drug delivery. Pre-assembled syringes, while beneficial, currently hold a smaller market share compared to the other two designs.

Single-Chamber (Dominant) vs. Dual-Chamber (Emerging)

Single-Chamber prefilled syringes are highly favored for their simplicity and efficiency, making them the predominant choice in the market. They are ideal for a variety of medications, including vaccines and biologics, allowing for easy and accurate dosing. On the other hand, Dual-Chamber syringes are gaining popularity due to their ability to separate medications that are sensitive to mixing, thus ensuring enhanced stability and efficacy. With healthcare providers increasingly focusing on personalized medicine, Dual-Chamber syringes are positioned as an emerging solution that meets the evolving needs for safe and effective drug delivery.

Get more detailed insights about Prefilled Syringes Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America is poised to maintain its leadership in the prefilled syringes market, holding a significant market share of 3.82 in 2024. The region's growth is driven by increasing demand for self-administration of medications, advancements in drug delivery technologies, and supportive regulatory frameworks. The FDA's focus on enhancing patient safety and efficacy in drug delivery systems further catalyzes market expansion.

The competitive landscape is robust, with key players like AbbVie, Becton Dickinson, and Medtronic leading the charge. The U.S. remains the largest market, supported by a strong healthcare infrastructure and high investment in R&D. Companies are increasingly focusing on innovative designs and materials to enhance usability and safety, ensuring a dynamic market environment.

Europe : Emerging Regulatory Frameworks

Europe's market is projected to grow significantly, with a market size of 2.3 by 2025. The region benefits from stringent regulatory standards that ensure product safety and efficacy, driving demand for high-quality prefilled syringes. The European Medicines Agency (EMA) has been instrumental in promoting innovations in drug delivery systems, which is expected to further boost market growth.

Leading countries such as Germany, France, and the UK are at the forefront of this market, with major players like Gerresheimer AG and Schott AG contributing to the competitive landscape. The presence of advanced manufacturing facilities and a focus on sustainability are key factors enhancing the region's market position. Companies are also investing in partnerships to expand their product offerings and improve market reach.

Asia-Pacific : Rapid Growth Potential

The Asia-Pacific region is witnessing rapid growth in the market, with a market size of 1.3 by 2025. Factors such as increasing healthcare expenditure, a growing aging population, and rising prevalence of chronic diseases are driving demand. Additionally, government initiatives aimed at improving healthcare infrastructure are expected to further propel market growth in this region.

Countries like Japan, China, and India are leading the market, with significant contributions from local manufacturers and global players like Nipro Corporation. The competitive landscape is evolving, with companies focusing on cost-effective solutions and innovative designs to cater to the diverse needs of the population. Collaborations and partnerships are also becoming common as firms seek to enhance their market presence.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa (MEA) region is gradually emerging in the global market, with a market size of 0.22 by 2025. The growth is primarily driven by increasing healthcare investments and a rising demand for advanced medical devices. Governments are focusing on improving healthcare access and quality, which is expected to create new opportunities for market players in the region. 

Countries like South Africa and the UAE are leading the way, with a growing number of healthcare facilities and increasing awareness of advanced drug delivery systems. The competitive landscape is still developing, with both local and international players vying for market share. Companies are exploring partnerships and collaborations to enhance their product offerings and expand their reach in this emerging market.

Prefilled Syringes Market Regional Image

Key Players and Competitive Insights

The Prefilled Syringes Market is characterized by a dynamic competitive landscape, driven by increasing demand for self-administration of medications and the growing prevalence of chronic diseases. Key players such as AbbVie (US), Becton Dickinson and Company (US), and Gerresheimer AG (DE) are strategically positioned to leverage innovation and technological advancements. AbbVie (US) focuses on enhancing patient experience through user-friendly designs, while Becton Dickinson and Company (US) emphasizes its commitment to sustainability and efficiency in production.
 
Gerresheimer AG (DE) is actively pursuing partnerships to expand its product offerings, thereby shaping a competitive environment that prioritizes innovation and responsiveness to market needs. In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The global market appears moderately fragmented, with several players vying for market share. The collective influence of these key players fosters a competitive structure that encourages continuous improvement and adaptation to emerging trends. 
 
In November 2025, AbbVie (US) announced a collaboration with a leading technology firm to develop smart prefilled syringes equipped with digital health monitoring capabilities. This strategic move is likely to enhance patient adherence and provide real-time data to healthcare providers, thereby positioning AbbVie at the forefront of innovation in the global market. In October 2025, Becton Dickinson and Company (US) unveiled a new manufacturing facility in Europe, aimed at increasing production capacity for prefilled syringes. 
 
This expansion not only signifies Becton Dickinson's commitment to meeting rising global demand but also reflects a strategic focus on regional supply chain optimization, potentially reducing costs and improving delivery times. In September 2025, Gerresheimer AG (DE) entered into a strategic partnership with a biotech company to co-develop a new line of prefilled syringes tailored for biologics. This collaboration underscores the growing trend towards personalized medicineand highlights Gerresheimer's proactive approach to aligning its product portfolio with market demands.
 
As of December 2025, the competitive trends in the global market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming pivotal in shaping the landscape, as companies seek to enhance their technological capabilities and product offerings. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to adapt to these evolving trends.

Key Companies in the Prefilled Syringes Market include

Industry Developments

Recent developments in the Global Prefilled Syringes Market indicate a growing demand for these products, driven largely by the increased need for vaccinations and biologics. In September 2023, AbbVie expanded its capabilities by launching a new fill-finish plant for prefilled syringes, enhancing its production efficiency. Similarly, in October 2023, Becton Dickinson announced an investment to increase its manufacturing capacity for prefilled syringes to meet global demand spikes. The global market has also seen significant financial growth, with major companies like Gerresheimer and Schott AG reporting increases in market valuation due to rising orders from pharmaceutical firms for vaccine delivery.

A notable merger took place in August 2022, when West Pharmaceutical Services acquired a technology firm focused on developing intelligent drug delivery solutions, positioning itself strongly in the market. Additionally, Terumo Corporation and Mediq have collaborated on new sustainable prefilled syringe designs, emphasizing the industry's shift towards eco-friendly solutions. Over the last couple of years, the pandemic's pressures have catalyzed innovations in the prefilled syringes space, with a focus on enhancing usability and safety within healthcare settings globally.

Future Outlook

Prefilled Syringes Market Future Outlook

The Prefilled Syringes Market size is projected to reach USD 20.63 Billion by 2035, growing at a CAGR of 9.45%, driven by increasing demand for self-administration and advancements in drug delivery technologies.

New opportunities lie in:

  • Expansion into emerging markets with tailored product offerings. Development of smart prefilled syringes with integrated monitoring systems. Partnerships with telehealth platforms for remote patient management solutions.

By 2035, the Prefilled Syringes Market is expected to achieve substantial growth and innovation.

Market Segmentation

Prefilled Syringes Market End Use Outlook

  • Hospitals
  • Home Care
  • Ambulatory Surgical Centers
  • Pharmacies

Prefilled Syringes Market Material Outlook

  • Glass
  • Plastic
  • Rubber
  • Metal

Prefilled Syringes Market Application Outlook

  • Vaccination
  • Autoimmune Diseases
  • Diabetes
  • Oncology
  • Hormonal Disorders

Prefilled Syringes Market Design Type Outlook

  • Single-Chamber
  • Dual-Chamber
  • Pre-assembled

Prefilled Syringes Market Filling Volume Outlook

  • Less than 1 ml
  • 1 ml to 5 ml
  • More than 5 ml

Report Scope

MARKET SIZE 2024 7.64(USD Billion)
MARKET SIZE 2025 8.36(USD Billion)
MARKET SIZE 2035 20.63(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 9.45% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled AbbVie (US), Becton Dickinson and Company (US), Gerresheimer AG (DE), Schott AG (DE), Fresenius Kabi AG (DE), Syringe Manufacturing Corporation (US), Medtronic (US), West Pharmaceutical Services (US), Nipro Corporation (JP)
Segments Covered Application, End Use, Material, Filling Volume, Design Type
Key Market Opportunities Advancements in biopharmaceuticals drive demand for innovative Prefilled Syringes Market solutions.
Key Market Dynamics Rising demand for self-administration drives innovation and competition in the prefilled syringes market.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

FAQs

What is the projected market valuation of the market by 2035?

The market is projected to reach a valuation of 20.63 USD Billion by 2035.

What was the market valuation of the market in 2024?

In 2024, the Prefilled Syringes Market was valued at 7.64 USD Billion.

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 9.45%.

Which companies are considered key players in the Prefilled Syringes Market?

Key players in the Prefilled Syringes Market include AbbVie, Becton Dickinson and Company, Gerresheimer AG, and others.

What are the main applications driving the Prefilled Syringes Market?

Main applications include Vaccination, Autoimmune Diseases, Diabetes, Hormonal Disorders, and Oncology.

How does the market for prefilled syringes in hospitals compare to home care settings?

The market for prefilled syringes in hospitals was valued at 2.5 USD Billion in 2024 and is projected to reach 6.5 USD Billion.

What filling volume segments are present in the Prefilled Syringes Market?

Filling volume segments include Less than 1 ml, 1 ml to 5 ml, and More than 5 ml.

What materials are predominantly used in the production of prefilled syringes?

The predominant materials used include Glass, Plastic, and Rubber.

What design types are available in the Prefilled Syringes Market?

Available design types include Single-Chamber, Dual-Chamber, and Pre-assembled.

How does the market for prefilled syringes in pharmacies compare to ambulatory surgical centers?

The market for prefilled syringes in pharmacies was valued at 2.64 USD Billion in 2024 and is projected to reach 7.63 USD Billion.

Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, pharmacopeial standards, peer-reviewed pharmaceutical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health, European Medicines Agency (EMA), United States Pharmacopeia (USP) Chapter <1382>/<1790> (Assessment of Package and Delivery System Integrity), International Organization for Standardization (ISO 11040 series for Prefilled Syringes), World Health Organization (WHO) Prequalification Programme and Immunization Dashboard, Centers for Disease Control and Prevention (CDC) Vaccine Storage & Handling Toolkit, National Institutes of Health (NIH)/PubMed database for drug delivery research, FDA MAUDE (Manufacturer and User Facility Device Experience) Database for adverse event analysis, Parenteral Drug Association (PDA) Technical Reports, International Society for Pharmaceutical Engineering (ISPE) Good Practice Guides, Pharmaceutical Research and Manufacturers of America (PhRMA) pipeline databases, EFPIA (European Federation of Pharmaceutical Industries and Associations), National Center for Health Statistics (CDC) ambulatory care surveys, OECD Health Statistics, WHO Global Health Observatory (vaccination coverage data), and national regulatory filings including FDA 510(k) clearances and EudraVigilance safety reports. These sources were utilized to collect regulatory approval pathways, pharmaceutical packaging standards, biologics pipeline data, vaccination program statistics, adverse event reporting trends, and pharmaceutical manufacturing capacity data for glass-based, plastic-based, and specialty material prefilled syringes across liquid, lyophilized, and powder filling formats.

 

Primary Research

Supply-side and demand-side stakeholders were consulted through structured interviews, surveys, and expert consultations during the primary research process to acquire qualitative and quantitative insights that were specific to pharmaceutical packaging and parenteral delivery systems. Vice Presidents of Business Development, Chief Executive Officers, Heads of Regulatory Affairs for Combination Products, Chief Technology Officers of materials science divisions, and Commercial Directors from prefilled syringe manufacturers, contract manufacturing organizations (CMOs), and pharmaceutical primary packaging suppliers comprised the supply-side sources. The demand-side sources included Executive Directors of Pharmacy Operations at integrated delivery networks (IDNs), Biopharmaceutical Manufacturing Heads and Supply Chain Directors from companies developing injectable biologics, Clinical Trial Supply Managers, Home Healthcare Program Directors, Procurement Leads from hospital systems and specialty clinics, and Key Opinion Leaders (KOLs) in therapeutic areas including endocrinology (diabetes management), oncology, rheumatology (autoimmune diseases), and infectious disease (vaccination programs). Primary research provided validation for market segmentation across material types (glass, plastic polymer, metal), filling formats (liquid, lyophilized dual-chamber, powder), and therapeutic applications. It also confirmed product innovation timelines, including connected and gathered insights on regulatory compliance strategies, pharmaceutical compatibility testing protocols, self-administration adoption patterns, cold chain logistics requirements, and pricing dynamics for single-chamber versus multi-chamber delivery systems.

Primary Respondent Breakdown:

• By Designation: C-level Executives (30%), Vice Presidents/Directors (35%), Managers/Technical Leads (35%)

• By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Global market valuation was derived through pharmaceutical industry revenue mapping, unit volume analysis, and procurement data triangulation specific to parenteral delivery systems. The methodology included:

• Identification of 50+ key manufacturers and component suppliers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, including glass forming specialists, cyclic olefin polymer (COP)/cyclic olefin copolymer (COC) manufacturers, integrated safety needle systems providers, and contract development manufacturing organizations (CDMOs)

• Product mapping across glass syringes (Type I borosilicate), plastic syringes (COP, COC, polypropylene), and metal/plunger systems; segmented by filling type (liquid, lyophilized, powder); application areas (vaccination, diabetes management, oncology, autoimmune diseases, hormonal therapy); and end-use settings (hospitals, home healthcare, pharmaceutical companies, research laboratories)

• Analysis of reported and modeled annual revenues specific to prefilled syringe portfolios, needle safety devices, and integrated combination product divisions

• Coverage of manufacturers representing 75-80% of global market share in 2024, with particular emphasis on ISO 11040-compliant manufacturers and WHO-prequalified suppliers for immunization programs

• Extrapolation using bottom-up (pharmaceutical dose volume × units per indication × average selling price by country/region) and top-down (manufacturer revenue validation, pharmaceutical packaging industry reports, IQVIA prescription data analysis) approaches to derive segment-specific valuations for material types, therapeutic applications, and regional markets

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓